CAS: 52869-18-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N1-(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide REF: IN-DA01CAW1CAS: 52869-18-8 | 95% | To inquire | Mon 16 Dec 24 |
 | SSAA09E3 REF: TM-T9293CAS: 52869-18-8 | 99.62% | 71.00 €~1,068.00 € | Mon 23 Dec 24 |
 | N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide REF: 3D-CCA86918CAS: 52869-18-8 | Min. 95% | To inquire | Mon 27 Jan 25 |
N1-(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide
CAS:52869-18-8
Formula:
C21H13NO3
Purity:
95%
Color and Shape:
Solid
Molecular weight:
327.3328
Ref: IN-DA01CAW1
| 10mg | 160.00 € | ||
| 25mg | 316.00 € | ||
| 50mg | 506.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
SSAA09E3
CAS:52869-18-8
SSAA09E3 is a novel inhibitor of SARS-CoV replication, acting by preventing fusion of the viral …
Formula:
C21H13NO3
Purity:
99.62%
Color and Shape:
Solid
Molecular weight:
327.33
Ref: TM-T9293
| 5mg | 71.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 187.00 € | ||
| 50mg | 312.00 € | ||
| 100mg | 506.00 € | ||
| 500mg | 1,068.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide
CAS:52869-18-8
N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide is a medicinal compound that has shown promising results in the treatment of cancer. …
Formula:
C21H13NO3
Purity:
Min. 95%
Molecular weight:
327.3 g/mol
Ref: 3D-CCA86918
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
